{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T17:03:20Z","timestamp":1790960600125,"version":"4.1.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Rheumatol"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/s12969-015-0047-3","type":"journal-article","created":{"date-parts":[[2015,11,20]],"date-time":"2015-11-20T07:57:13Z","timestamp":1448006233000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":121,"title":["Gene-expression analysis of adult-onset Still\u2019s disease and systemic juvenile idiopathic arthritis is consistent with a continuum of a single disease entity"],"prefix":"10.1186","volume":"13","author":[{"given":"Nanguneri","family":"Nirmala","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arndt","family":"Brachat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugen","family":"Feist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norbert","family":"Blank","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christof","family":"Specker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Witt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Zernicke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Martini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guido","family":"Junge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,11,20]]},"reference":[{"key":"47_CR1","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s12026-014-8561-9","volume":"61","author":"Y Jamilloux","year":"2015","unstructured":"Jamilloux Y, Gerfaud-Ventin M, Martinon F, Belot A, Henry T, S\u00e8ve P. Pathogenesis of adult-onset Still\u2019s disease: new insights from the juvenile counterpart. Immunol Res. 2015;61:53\u201362.","journal-title":"Immunol Res"},{"key":"47_CR2","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1136\/annrheumdis-2012-201388","volume":"71","author":"A Martini","year":"2012","unstructured":"Martini A. It is time to rethink juvenile idiopathic arthritis classification and nomenclature. Ann Rheum Dis. 2012;71:1437\u20139.","journal-title":"Ann Rheum Dis"},{"key":"47_CR3","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/j.berh.2008.08.006","volume":"22","author":"B Fautrel","year":"2008","unstructured":"Fautrel B. Adult-onset Still disease. Best Pract Res Clin Rheumatol. 2008;22:773\u201392.","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"47_CR4","first-page":"427","volume":"20","author":"F Luthi","year":"2002","unstructured":"Luthi F, Zufferey P, Hofer MF, So AK. \u201cAdolescent-onset Still\u2019s disease\u201d: characteristics and outcome in comparison with adult-onset Still\u2019s disease. Clin Exp Rheumatol. 2002;20:427\u201330.","journal-title":"Clin Exp Rheumatol"},{"key":"47_CR5","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1093\/rheumatology\/34.5.429","volume":"34","author":"SS Uppal","year":"1995","unstructured":"Uppal SS, Pande IR, Kumar A, Kailash S, Sekharan NG, Adya CM, et al. Adult onset Still\u2019s disease in northern India: comparison with juvenile onset Still\u2019s disease. Br J Rheumatol. 1995;34:429\u201334.","journal-title":"Br J Rheumatol"},{"key":"47_CR6","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1177\/095952879708000106","volume":"80","author":"GF Still","year":"1897","unstructured":"Still GF. On a form of chronic joint disease in children. Med Chir Trans. 1897;80:47\u201360.9.","journal-title":"Med Chir Trans"},{"key":"47_CR7","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1111\/j.0906-6705.2005.00271.x","volume":"14","author":"M Frosch","year":"2005","unstructured":"Frosch M, Metze D, Foell D, Vogl T, Sorg C, Sunderk\u00f6tter C, et al. Early activation of cutaneous vessels and epithelial cells is characteristic of acute systemic onset juvenile idiopathic arthritis. Exp Dermatol. 2005;14:259\u201365.","journal-title":"Exp Dermatol"},{"key":"47_CR8","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.3899\/jrheum.120079","volume":"39","author":"HA Kim","year":"2012","unstructured":"Kim HA, An JM, Nam JY, Jeon JY, Suh CH. Serum S100A8\/A9, but not follistatin-like protein 1 and interleukin 18, may be a useful biomarker of disease activity in adult-onset Still\u2019s disease. J Rheumatol. 2012;39:1399\u2013406.","journal-title":"J Rheumatol"},{"key":"47_CR9","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.1093\/rheumatology\/keq284","volume":"49","author":"D-Y Chen","year":"2010","unstructured":"Chen D-Y, Chen Y-M, Lan J-L, Lin C-C, Chen H-H. Potential role of TH17 cells in the pathogenesis of adult-onset Still\u2019s disease. Rheumatology. 2010;49:2305\u201312.","journal-title":"Rheumatology"},{"key":"47_CR10","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.semarthrit.2007.04.002","volume":"37","author":"I K\u00f6tter","year":"2007","unstructured":"K\u00f6tter I, Wacker A, Koch S, Henes J, Richter C, Engel A, et al. Anakinra in patients with treatment-resistant adult-onset Still\u2019s disease: four case reports with serial cytokine measurements and a review of the literature. Semin Arthritis Rheum. 2007;37:189\u201397.","journal-title":"Semin Arthritis Rheum"},{"key":"47_CR11","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.cytogfr.2014.05.005","volume":"26","author":"A Avau","year":"2015","unstructured":"Avau A, Put K, Wouters CH, Matthys P. Cytokine balance and cytokine-driven natural killer cell dysfunction in systemic juvenile idiopathic arthritis. Cytokine Growth Factor Rev. 2015;26:35\u201345.","journal-title":"Cytokine Growth Factor Rev"},{"key":"47_CR12","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1007\/s00296-008-0825-z","volume":"29","author":"FH F\u00e9lix","year":"2009","unstructured":"F\u00e9lix FH, Leal LK, Fontenele JB. Cloak and dagger: the case for adult onset still disease and hemophagocytic lymphohistiocytosis. Rheumatol Int. 2009;29:973\u20134.","journal-title":"Rheumatol Int"},{"key":"47_CR13","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/gene.2012.3","volume":"13","author":"A Ravelli","year":"2012","unstructured":"Ravelli A, Grom AA, Behrens EM, Cron RQ. Macrophage activation syndrome as part of systemic juvenile idiopathic arthritis: diagnosis, genetics, pathophysiology and treatment. Genes Immun. 2012;13:289\u201398.","journal-title":"Genes Immun"},{"key":"47_CR14","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1084\/jem.20050473","volume":"201","author":"V Pascual","year":"2005","unstructured":"Pascual V, Allantaz F, Arce E, Punaro M, Banchereau J. Role of interleukin-1 (IL-1) in the pathogenesis of systemic onset juvenile idiopathic arthritis and clinical response to IL-1 blockade. J Exp Med. 2005;201:1479\u201386.","journal-title":"J Exp Med"},{"key":"47_CR15","doi-asserted-by":"crossref","first-page":"3793","DOI":"10.1002\/art.22981","volume":"56","author":"N Fall","year":"2007","unstructured":"Fall N, Barnes M, Thornton S, Luyrink L, Olson J, Ilowite NT, et al. Gene expression profiling of peripheral blood from patients with untreated new-onset systemic juvenile idiopathic arthritis reveals molecular heterogeneity that may predict macrophage activation syndrome. Arthritis Rheum. 2007;56:3793\u2013804.","journal-title":"Arthritis Rheum"},{"key":"47_CR16","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1002\/art.33342","volume":"64","author":"N Ruperto","year":"2012","unstructured":"Ruperto N, Quartier P, Wulffraat N, Woo P, Ravelli A, Mouy R, et al. A phase II, multicenter, open-label study evaluating dosing and preliminary safety and efficacy of canakinumab in systemic juvenile idiopathic arthritis with active systemic features. Arthritis Rheum. 2012;64:557\u201367.","journal-title":"Arthritis Rheum"},{"key":"47_CR17","doi-asserted-by":"crossref","first-page":"2396","DOI":"10.1056\/NEJMoa1205099","volume":"367","author":"N Ruperto","year":"2012","unstructured":"Ruperto N, Brunner HI, Quartier P, Constantin T, Wulfraat N, Horneff G, et al. Two randomized trials of canakinumab in systemic juvenile idiopathic arthritis. N Engl J Med. 2012;367:2396\u2013406.","journal-title":"N Engl J Med"},{"key":"47_CR18","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.semarthrit.2012.03.004","volume":"42","author":"A Kontzias","year":"2012","unstructured":"Kontzias A, Efthimiou P. The use of Canakinumab, a novel IL-1\u03b2 long-acting inhibitor, in refractory adult-onset Still\u2019s disease. Semin Arthritis Rheum. 2012;42:201\u20135.","journal-title":"Semin Arthritis Rheum"},{"key":"47_CR19","doi-asserted-by":"crossref","first-page":"R91","DOI":"10.1186\/ar3366","volume":"13","author":"K Laskari","year":"2011","unstructured":"Laskari K, Tzioufas AG, Moutsopoulos HM. Efficacy and long-term follow-up of IL-1R inhibitor anakinra in adults with Still\u2019s disease: a case-series study. Arthritis Res Ther. 2011;13:R91.","journal-title":"Arthritis Res Ther"},{"key":"47_CR20","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1038\/ncprheum0510","volume":"3","author":"P Efthimiou","year":"2007","unstructured":"Efthimiou P, Kontzias A, Ward CM, Ogden NS. Adult-onset Still\u2019s disease: can recent advances in our understanding of its pathogenesis lead to targeted therapy? Nat Clin Pract Rheumatol. 2007;3:328\u201335.","journal-title":"Nat Clin Pract Rheumatol"},{"key":"47_CR21","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1002\/art.21061","volume":"52","author":"AA Fitzgerald","year":"2005","unstructured":"Fitzgerald AA, Leclercq SA, Yan A, Hornik JE, Dinarello CA. Rapid responses to anakinra in patients with refractory adult-onset Still\u2019s disease. Arthritis Rheum. 2005;52:1794\u2013803.","journal-title":"Arthritis Rheum"},{"key":"47_CR22","doi-asserted-by":"crossref","first-page":"2056","DOI":"10.1136\/annrheumdis-2012-201409","volume":"71","author":"O Petryna","year":"2012","unstructured":"Petryna O, Cush JJ, Efthimiou P. IL-1 Trap rilonacept in refractory adult onset Still\u2019s disease. Ann Rheum Dis. 2012;71:2056\u20137.","journal-title":"Ann Rheum Dis"},{"key":"47_CR23","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.3899\/jrheum.111549","volume":"39","author":"D, Nordstr\u00f6m","year":"2012","unstructured":"Nordstr\u00f6m D, Knight A, Luukkainen R, van Vollenhaven R, Rantalaiho V, Kajalainen A, et al. Beneficial effect of interleukin 1 inhibition with anakinra in adult-onset Still\u2019s disease. An open, randomized, multicenter study. J Rheumatol. 2012;39:2008\u201311.","journal-title":"J Rheumatol"},{"key":"47_CR24","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1136\/ard.2009.108068","volume":"69","author":"L Naumann","year":"2010","unstructured":"Naumann L, Feist E, Natusch A, Langen S, Krause A, Buttgereit F, et al. IL1-receptor antagonist anakinra provides long-lasting efficacy in the treatment of refractory adult-onset Still\u2019s disease. Ann Rheum Dis. 2010;69:466\u20137.","journal-title":"Ann Rheum Dis"},{"issue":"Suppl2","key":"47_CR25","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1136\/annrheumdis-2014-eular.2320","volume":"73","author":"A Brachat","year":"2014","unstructured":"Brachat A, Grom A, Wulffraat N, Brunner H, Quartier P, Brik R, et al. Changes in gene expression and inflammatory proteins in systemic juvenile idiopathic arthritis patients on canakinumab therapy. Ann Rheum Dis. 2014;73(Suppl2):62.","journal-title":"Ann Rheum Dis"},{"key":"47_CR26","unstructured":"ClinicalTrials.gov. NCT02204293. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02204293 . Accessed November 18, 2015."},{"key":"47_CR27","doi-asserted-by":"crossref","first-page":"2176","DOI":"10.1093\/bioinformatics\/btq401","volume":"26","author":"D Wu","year":"2010","unstructured":"Wu D, Lim E, Vaillant F, Asselin-Labat ML, Visvader JE, Smyth GK. ROAST: rotation gene set tests for complex microarray experiments. Bioinformatics. 2010;26:2176\u201382.","journal-title":"Bioinformatics"}],"container-title":["Pediatric Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12969-015-0047-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,23]],"date-time":"2017-06-23T20:02:46Z","timestamp":1498248166000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.ped-rheum.com\/content\/13\/1\/50"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11,20]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["47"],"URL":"https:\/\/doi.org\/10.1186\/s12969-015-0047-3","relation":{},"ISSN":["1546-0096"],"issn-type":[{"value":"1546-0096","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,11,20]]},"article-number":"50"}}